Furthermore, we demonstrated that differential expression of all investigated Ibrutinib target genes (i.e., BTK, EGFR, ERBB2, ITK, JAK3, and TEC) is associated with apoptotic mechanisms in clinical melanoma samples (Figure 7). Here, ITK is linked to melanoma.